Research conducted by VA investigators aims to design prostate and breast cancer radio therapeutic treatments by using conventional chemotherapy to enhance targeted radiotherapy as a means to achieve better outcomes and fewer/decreased side effects
A Phase 3B Randomized Study of Lenalidomide (cc-5013) Plus Rituximab Maintenance Therapy Followed by Lenalidomide Single-Agent Maintenance vs Rituximab Maintenance in Subjects with Relapsed/Refractory Follicular Marginal Zone or Mantle Cell Lymphoma, “The Magnify Trial”
The clinical trials in which the Truman VA chooses to participate look at cancer therapies in organized, detailed ways. Clinical trials are the only way to find out what new approaches to prevention, screening, treatment and survival work better than existing ones.
The Alliance for Clinical Trials in Oncology develops and conducts clinical trials with promising new cancer therapies, and utilizes the best science to develop optimal treatment and prevention strategies for cancer, as well as researches methods to alleviate side effects of cancer and cancer treatments.